METHYLDOPA AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; METHYLDOPA) — FDA Approval ANDA070265 (RISING)
METHYLDOPA AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; METHYLDOPA) — FDA Approval ANDA070265 (RISING) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: METHYLDOPA AND HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; METHYLDOPA; Application number: ANDA070265.
| Brand name | METHYLDOPA AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE; METHYLDOPA |
| Application number | ANDA070265 |
| Sponsor | RISING |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19860123 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →